In contrast, both expression and specific activation of ERβ which is downregulated in most ovarian cancer cases, reduces ovarian cancer cell proliferation (Halon et al. 2011; Schüler-Toprak et al. 2017; Treeck et al. 2007). The gene discussed is ESR2; the disease is ovarian cancer.